Gut Microbiota Pilot Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-01

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Microbiota is known to effect metabolism. This is pilot study to get status of microbiota from normal control. It will be compared to data from specific patients in ICU via further study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gut Microbiota Pilot Study

NCT03897023

Microbiota Metabolism

UNKNOWN

Study of the Intestinal Microbiota

NCT07058961

Intestinal Microbiota Between Different Groups

RECRUITING

Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc)

NCT06095076

Dysbiosis Catheter-Related Infections

UNKNOWN

Microbiota Study in Liver Transplanted Patients

NCT03507140

Cirrhosis Hepatocellular Carcinoma Liver Transplant +1 more

COMPLETED

Implications of the Human Microbiota for Health and Disease

NCT04203303

Human Microbiota

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Microbiota is known to effect metabolism. Patients in specific conditions like hypovolemic shock, sepsis might have changes in status of microbiota. This is pilot study to get status of microbiota from normal control. Stable patient who are admitted to ICU for observation will be gathered. Samples will be collected via rectal swab at time of admission and analyzed via Next generation sequencing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Microbiota Metabolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stable patient

Stable patients who admitted to ICU for observation.

Gut microbiota

Intervention Type BIOLOGICAL

Status of microbiota

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gut microbiota

Status of microbiota

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Older than 17 years old
* Every patients who are admitted to ICU

Exclusion Criteria

* With history of disease such as cancer, Crohn's disease, ulcerative colitis, irritable bowel syndrome
* With history of immunosuppressive agents.
* Initial systolic blood pressure \<100
* Initial pulse rate \> 100
* Need emergent operation at brain or torso
* Need vasopressor, transfusion

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No